Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

The Chaperone Activities of DsbG and Spy Restore Peptidoglycan Biosynthesis in the elyC Mutant by Preventing Envelope Protein Aggregation.

Kouidmi I, Alvarez L, Collet JF, Cava F, Paradis-Bleau C.

J Bacteriol. 2018 Sep 10;200(19). pii: e00245-18. doi: 10.1128/JB.00245-18. Print 2018 Oct 1.

2.

Adaptation of a bacterial membrane permeabilization assay for quantitative evaluation of benzalkonium chloride as a membrane-disrupting agent.

Gravel J, Paradis-Bleau C, Schmitzer AR.

Medchemcomm. 2017 May 2;8(7):1408-1413. doi: 10.1039/c7md00113d. eCollection 2017 Jul 1.

3.

Biology and Assembly of the Bacterial Envelope.

Dufresne K, Paradis-Bleau C.

Adv Exp Med Biol. 2015;883:41-76. doi: 10.1007/978-3-319-23603-2_3. Review.

PMID:
26621461
4.

The biology of Mur ligases as an antibacterial target.

Kouidmi I, Levesque RC, Paradis-Bleau C.

Mol Microbiol. 2014 Oct;94(2):242-53. doi: 10.1111/mmi.12758. Epub 2014 Sep 5. Review.

5.

A genome-wide screen for bacterial envelope biogenesis mutants identifies a novel factor involved in cell wall precursor metabolism.

Paradis-Bleau C, Kritikos G, Orlova K, Typas A, Bernhardt TG.

PLoS Genet. 2014 Jan;10(1):e1004056. doi: 10.1371/journal.pgen.1004056. Epub 2014 Jan 2.

6.

Lipoprotein cofactors located in the outer membrane activate bacterial cell wall polymerases.

Paradis-Bleau C, Markovski M, Uehara T, Lupoli TJ, Walker S, Kahne DE, Bernhardt TG.

Cell. 2010 Dec 23;143(7):1110-20. doi: 10.1016/j.cell.2010.11.037.

7.

Caveolin-1 modifies the immunity to Pseudomonas aeruginosa.

Gadjeva M, Paradis-Bleau C, Priebe GP, Fichorova R, Pier GB.

J Immunol. 2010 Jan 1;184(1):296-302. doi: 10.4049/jimmunol.0900604. Epub 2009 Nov 30.

8.

Biophysical studies of the interactions between the phage varphiKZ gp144 lytic transglycosylase and model membranes.

Cloutier I, Paradis-Bleau C, Giroux AM, Pigeon X, Arseneault M, Levesque RC, Auger M.

Eur Biophys J. 2010 Jan;39(2):263-76. doi: 10.1007/s00249-009-0530-1. Epub 2009 Aug 8.

PMID:
19669132
9.

Pseudomonas aeruginosa MurE amide ligase: enzyme kinetics and peptide inhibitor.

Paradis-Bleau C, Lloyd A, Sanschagrin F, Maaroufi H, Clarke T, Blewett A, Dowson C, Roper DI, Bugg TD, Levesque RC.

Biochem J. 2009 Jun 26;421(2):263-72. doi: 10.1042/BJ20081395.

PMID:
19400768
10.

Phage display-derived inhibitor of the essential cell wall biosynthesis enzyme MurF.

Paradis-Bleau C, Lloyd A, Sanschagrin F, Clarke T, Blewett A, Bugg TD, Levesque RC.

BMC Biochem. 2008 Dec 19;9:33. doi: 10.1186/1471-2091-9-33.

11.

Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.

Winstanley C, Langille MG, Fothergill JL, Kukavica-Ibrulj I, Paradis-Bleau C, Sanschagrin F, Thomson NR, Winsor GL, Quail MA, Lennard N, Bignell A, Clarke L, Seeger K, Saunders D, Harris D, Parkhill J, Hancock RE, Brinkman FS, Levesque RC.

Genome Res. 2009 Jan;19(1):12-23. doi: 10.1101/gr.086082.108. Epub 2008 Dec 1.

12.

Airway epithelial control of Pseudomonas aeruginosa infection in cystic fibrosis.

Campodónico VL, Gadjeva M, Paradis-Bleau C, Uluer A, Pier GB.

Trends Mol Med. 2008 Mar;14(3):120-33. doi: 10.1016/j.molmed.2008.01.002. Epub 2008 Feb 11. Review.

13.

Discovery of new MurF inhibitors via pharmacophore modeling and QSAR analysis followed by in-silico screening.

Taha MO, Atallah N, Al-Bakri AG, Paradis-Bleau C, Zalloum H, Younis KS, Levesque RC.

Bioorg Med Chem. 2008 Feb 1;16(3):1218-35. Epub 2007 Nov 7.

PMID:
17988876
14.

Peptidoglycan lytic activity of the Pseudomonas aeruginosa phage phiKZ gp144 lytic transglycosylase.

Paradis-Bleau C, Cloutier I, Lemieux L, Sanschagrin F, Laroche J, Auger M, Garnier A, Levesque RC.

FEMS Microbiol Lett. 2007 Jan;266(2):201-9.

15.

Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.

Paradis-Bleau C, Beaumont M, Sanschagrin F, Voyer N, Levesque RC.

Bioorg Med Chem. 2007 Feb 1;15(3):1330-40. Epub 2006 Nov 10.

PMID:
17157508
16.

Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme.

Paradis-Bleau C, Beaumont M, Boudreault L, Lloyd A, Sanschagrin F, Bugg TD, Levesque RC.

Peptides. 2006 Jul;27(7):1693-700. Epub 2006 Mar 6.

PMID:
16517013
17.

Peptide inhibitors of the essential cell division protein FtsA.

Paradis-Bleau C, Sanschagrin F, Levesque RC.

Protein Eng Des Sel. 2005 Feb;18(2):85-91. Epub 2005 Mar 24.

PMID:
15790573
18.

Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials.

Paradis-Bleau C, Sanschagrin F, Levesque RC.

J Antimicrob Chemother. 2004 Jul;54(1):278-80. Epub 2004 Jun 9. No abstract available.

PMID:
15190020
19.

Ultrastructural and cytochemical study of cell wall modification by lactoferrin, lactoferricin and penicillin G against Staphylococcus aureus.

Diarra MS, Lacasse P, Deschênes E, Grondin G, Paradis-Bleau C, Petitclerc D.

J Electron Microsc (Tokyo). 2003;52(2):207-15.

PMID:
12868591

Supplemental Content

Loading ...
Support Center